Using Metabolite Data to Develop Patient Centric Specification for Amide Impurity in Vildagliptin Tablets
Many specified impurities in vildagliptin's finished product have been disclosed in the literature that are above their qualification threshold. We used the impurity B (amide impurity) as a case example to explore whether existing literature can be leveraged to determine the safe level of impur...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Книга |
| Опубліковано: |
MDPI AG,
2021-12-01T00:00:00Z.
|
| Предмети: | |
| Онлайн доступ: | Connect to this object online. |
| Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
Інтернет
Connect to this object online.3rd Floor Main Library
| Шифр: |
A1234.567 |
|---|---|
| Примірник 1 | Доступно |